Investigational Site Number 528003

Rotterdam 3083 AN

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Diabetes Mellitus, Type 2, Neoplasm Malignant, Venous Thromboembolism

Studies at this site

• Phase 1 Safety Testing of SAR405838 — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed